SETD2 and cancer: HIF-1 signaling suppresses the immune system in the hypoxic TME, allowing cancer cells to evade immune responses by triggering the expression of immunosuppressive molecules (Barsoum et al., 2014; Semenza, 2014; Schito and Semenza, 2016; Jiang et al., 2019; You et al., 2021).